Sjögren’s syndrome is a chronic autoimmune disease in which the immune system attacks the moisture-producing glands of the body, primarily the salivary and tear glands. Estimates suggest 1 to 4 million Americans have the disease, with women outnumbering men 9 to 1 and the average age at diagnosis falling between 40 and 60 according to the NIAMS. While the dry eyes and dry mouth that define Sjögren’s can sound mild, the disease is systemic — it can affect joints, lungs, kidneys, nerves, and blood, and it carries a substantially elevated risk of non-Hodgkin lymphoma.
The Defining Symptoms
Dry eye in Sjögren’s is more than mild irritation. Patients describe a gritty, sandy, or burning sensation, blurry vision that comes and goes, light sensitivity, and a feeling that something is in the eye. Severe cases produce corneal damage that requires aggressive ophthalmologic management.
Dry mouth (xerostomia) creates difficulty swallowing dry foods, altered taste, dramatic increases in dental cavities (sometimes a decade’s worth in a year), persistent oral yeast infections, and difficulty wearing dentures. The mouth often appears glossy and red rather than wet. Salivary gland enlargement, particularly of the parotids, can be intermittent or chronic.
Other dryness symptoms include dry skin, dry sinuses with frequent crusting, vaginal dryness causing painful intercourse, and dry trachea contributing to chronic cough. Per Cleveland Clinic, the dryness is often what brings patients in, but systemic features may dominate the long-term course.
Beyond Dryness: Systemic Features
Fatigue affects 70 to 80 percent of Sjögren’s patients and is often the most disabling symptom. Joint pain — usually inflammatory, with morning stiffness — affects roughly half. Raynaud’s phenomenon, peripheral neuropathy, interstitial lung disease, kidney involvement (typically interstitial nephritis or distal renal tubular acidosis), autoimmune hepatitis, and cytopenias all occur.
Cognitive symptoms — brain fog, difficulty concentrating, word-finding problems — are common and often dismissed. Small-fiber neuropathy producing burning pain in the feet without abnormalities on standard nerve conduction studies has been increasingly recognized. The disease overlaps significantly with other autoimmune conditions; about 30 percent of patients have a second autoimmune diagnosis like lupus, rheumatoid arthritis, or autoimmune thyroid disease. Our lupus guide covers another connective tissue disease that can coexist with Sjögren’s.
Diagnosis
The 2016 ACR/EULAR criteria require at least three points from weighted features: anti-SSA/Ro positivity (3 points), abnormal ocular staining (1), abnormal Schirmer test (1), abnormal unstimulated salivary flow (1), and characteristic minor salivary gland biopsy (3 points). At least one of the first two ophthalmologic items or the biopsy is typically required.
Anti-Ro/SSA antibodies are present in about 70 percent of Sjögren’s patients; anti-La/SSB in 30 to 40 percent. ANA is positive in most patients. Rheumatoid factor — interestingly — is positive in about half of patients, sometimes leading to misdiagnosis as RA. Hypergammaglobulinemia, low complement, and elevated ESR are common.
Lip biopsy taking minor salivary glands and showing focal lymphocytic sialadenitis with a focus score ≥1 supports diagnosis when serology is negative or equivocal. Salivary gland ultrasound is increasingly used as a non-invasive imaging adjunct.
Treating Dryness
Symptomatic management of dry eye includes preservative-free artificial tears used 4 to 8 times daily, gel lubricants at night, omega-3 supplementation, lid hygiene, and prescription anti-inflammatory drops (cyclosporine, lifitegrast). Punctal plugs reduce tear drainage and help selected patients. Severe cases may need autologous serum tears or scleral lenses.
Dry mouth management involves frequent water sipping, sugar-free gum and lozenges to stimulate flow, saliva substitutes, careful dental care with high-fluoride toothpaste and frequent cleanings, and avoidance of mouth-drying medications when possible. Pilocarpine or cevimeline — muscarinic agonists — stimulate residual gland function for many patients but can cause sweating and GI side effects.
Vaginal moisturizers and lubricants help with vulvovaginal dryness; topical estrogens may be appropriate for postmenopausal women per gynecology guidance.
Systemic Therapy
For severe systemic disease, hydroxychloroquine is commonly used despite mixed trial evidence — it may help fatigue, arthralgia, and skin manifestations. Methotrexate, azathioprine, mycophenolate, and rituximab are reserved for severe extra-glandular disease (interstitial lung disease, vasculitis, severe peripheral neuropathy, glomerulonephritis).
Corticosteroids are used for severe organ involvement but typically tapered as steroid-sparing immunosuppressants take effect. JAK inhibitors and several biologics are in clinical trials for Sjögren’s, with growing evidence supporting more targeted approaches per PMC reviews.
The Lymphoma Risk
Sjögren’s patients have roughly a 5 to 16-fold increased risk of non-Hodgkin lymphoma — typically MALT lymphoma of the parotid gland. Lifetime risk is approximately 5 to 10 percent. Risk factors include persistent salivary gland swelling, low complement levels, cryoglobulins, lymphadenopathy, and skin vasculitis.
Patients with these risk factors may need closer monitoring with periodic salivary gland imaging, careful lymph node exams, and prompt evaluation of any persistent gland enlargement. This elevated risk is one reason rheumatology follow-up matters even when dryness symptoms are stable.
When to seek emergency care: Call 911 or go to the nearest emergency room if you experience sudden severe shortness of breath (possible interstitial lung disease flare or pulmonary embolism), severe abdominal pain, signs of stroke, sudden severe headache, signs of serious infection while on immunosuppressants, sudden severe eye pain with vision loss, or new persistent painless lymph node swelling that is rapidly growing. Persistent or asymmetric salivary gland enlargement, especially when hard or fixed, warrants prompt evaluation for possible lymphoma.
Living With Sjögren’s
Daily routines build around dryness management. Frequent water, eye drops, gum, and humidifiers become habitual. Dental care intensifies — many patients see hygienists every 3 months and use prescription-strength fluoride. Avoiding caffeine and alcohol in excess, both of which worsen dryness, helps.
Fatigue management uses the same strategies as in lupus or fibromyalgia — pacing, prioritizing, regular gentle exercise, sleep hygiene, and sometimes pharmacologic support. Mood disorders are common and treatable. Our medical conditions overview covers chronic disease management more broadly.
When to See a Doctor
Persistent dry eye and dry mouth lasting more than 3 months, especially with fatigue, joint pain, or rapid dental decay, warrant evaluation. Primary care physicians can initiate workup with ANA, anti-Ro/La, and basic blood work; rheumatology referral is appropriate for confirmation and treatment.
Established patients need regular monitoring: rheumatology every 6 to 12 months when stable, annual eye exams, dental checks every 3 to 6 months, and periodic labs to monitor for lymphoma risk factors and organ involvement.
Frequently Asked Questions
Is Sjögren’s syndrome a disability?
It varies. Many patients function well with symptom management. Others experience disabling fatigue, neuropathy, or organ involvement that limits work and daily activities. Severe disease with significant systemic manifestations can qualify for disability benefits in the US.
Can Sjögren’s go into remission?
True remission is uncommon — most patients have ongoing dryness and require lifelong symptom management. However, periods of low disease activity with minimal systemic features are achievable for most patients. Inflammatory features often respond well to immunomodulatory therapy.
Is Sjögren’s syndrome inherited?
Genetic susceptibility plays a role, but Sjögren’s is not directly inherited. First-degree relatives have somewhat elevated risk of autoimmune disease in general. Most patients have no family history of Sjögren’s specifically.
What triggers Sjögren’s flares?
Common triggers include viral infections, dehydration, certain medications (antihistamines, decongestants, anticholinergics, diuretics), surgical stress, and emotional stress. UV exposure can trigger lupus-like flares in patients with overlap features.
The Bottom Line
Sjögren’s syndrome is more than a dryness condition — it is a systemic autoimmune disease with a distinctive lymphoma risk that warrants ongoing monitoring. Daily symptom management of dry eyes and dry mouth, prompt attention to dental care, and regular rheumatology follow-up remain the foundation of long-term care. Watch for new lymph node enlargement, persistent salivary gland swelling, lung symptoms, or numbness — those features change management. Modern recognition of the systemic nature of Sjögren’s, expanding therapeutic options, and growing patient communities all make the disease more manageable than even ten years ago, though the full toolkit still falls short of what patients deserve.